(2R,6R)-Hydroxynorketamine is not essential for the antidepressant actions of (R)-ketamine in mice. Yamaguchi, J., Toki, H., Qu, Y., Yang, C., Koike, H., Hashimoto, K., Mizuno-yasuhira, A., & Chaki, S. Neuropsychopharmacology, Nature Publishing Group, 5, 2018. ![(2R,6R)-Hydroxynorketamine is not essential for the antidepressant actions of (R)-ketamine in mice [pdf]](https://bibbase.org/img/filetypes/pdf.svg "pdf")
Paper ![(2R,6R)-Hydroxynorketamine is not essential for the antidepressant actions of (R)-ketamine in mice [link]](https://bibbase.org/img/filetypes/link.svg "link")
Website abstract bibtex (R,S)-Ketamine has rapid and sustained antidepressant effects in depressed patients. Although the metabolism of (R,S)-ketamine to (2 R,6 R)-hydroxynorketamine (HNK), a metabolite of (R)-ketamine, has been reported to be essential for its antidepressant effects, recent evidence suggests otherwise. The present study investigated the role of the metabolism of (R)-ketamine to (2 R,6 R)-HNK in the antidepressant actions of (R)-ketamine. Antidepressant effects were evaluated using the forced swimming test in the lipopolysaccharide (LPS)-induced inflammation model of mice and the tail suspension test in naive mice. To prevent the metabolism of (R)-ketamine to (2 R,6 R)-HNK, mice were pretreated with cytochrome P450 (CYP) inhibitors. The concentrations of (R)-ketamine, (R)-norketamine, and (2 R,6 R)-HNK in plasma, brain, and cerebrospinal fluid (CSF) samples were determined using enantioselective liquid chromatography-tandem mass spectrometry. The concentrations of (R)-norketamine and (2 R,6 R)-HNK in plasma, brain, and CSF samples after administration of (R)-norketamine (10 mg/kg) and (2 R,6 R)-HNK (10 mg/kg), respectively, were higher than those generated after administration of (R)-ketamine (10 mg/kg). Nonetheless, while (R)-ketamine attenuated, neither (R)-norketamine nor (2 R,6 R)-HNK significantly altered immobility times of LPS-treated mice. Treatment with CYP inhibitors prior to administration of (R)-ketamine increased the plasma levels of (R)-ketamine, while generation of (2 R,6 R)-HNK was almost completely blocked. (R)-Ketamine exerted the antidepressant effects at a lower dose in the presence of CYP inhibitors than in their absence, which is consistent with exposure levels of (R)-ketamine but not (2 R,6 R)-HNK. These results indicate that metabolism to (2 R,6 R)-HNK is not necessary for the antidepressant effects of (R)-ketamine and that unmetabolized (R)-ketamine itself may be responsible for its antidepressant actions.
@article{
title = {(2R,6R)-Hydroxynorketamine is not essential for the antidepressant actions of (R)-ketamine in mice},
type = {article},
year = {2018},
identifiers = {[object Object]},
pages = {0-1},
websites = {http://dx.doi.org/10.1038/s41386-018-0084-y},
month = {5},
publisher = {Nature Publishing Group},
day = {3},
id = {e5871c3f-12bf-37ff-9ebe-d201071ece8b},
created = {2018-05-12T15:03:35.733Z},
accessed = {2018-05-12},
file_attached = {true},
profile_id = {48f1fda5-0084-39cd-8cc7-68fcbd29ae85},
group_id = {d9389c6c-8ab5-3b8b-86ed-33db09ca0198},
last_modified = {2018-05-31T16:53:46.883Z},
tags = {CA},
read = {false},
starred = {false},
authored = {false},
confirmed = {true},
hidden = {false},
citation_key = {Yamaguchi2018},
notes = {FL},
private_publication = {false},
abstract = {(R,S)-Ketamine has rapid and sustained antidepressant effects in depressed patients. Although the metabolism of (R,S)-ketamine to (2 R,6 R)-hydroxynorketamine (HNK), a metabolite of (R)-ketamine, has been reported to be essential for its antidepressant effects, recent evidence suggests otherwise. The present study investigated the role of the metabolism of (R)-ketamine to (2 R,6 R)-HNK in the antidepressant actions of (R)-ketamine. Antidepressant effects were evaluated using the forced swimming test in the lipopolysaccharide (LPS)-induced inflammation model of mice and the tail suspension test in naive mice. To prevent the metabolism of (R)-ketamine to (2 R,6 R)-HNK, mice were pretreated with cytochrome P450 (CYP) inhibitors. The concentrations of (R)-ketamine, (R)-norketamine, and (2 R,6 R)-HNK in plasma, brain, and cerebrospinal fluid (CSF) samples were determined using enantioselective liquid chromatography-tandem mass spectrometry. The concentrations of (R)-norketamine and (2 R,6 R)-HNK in plasma, brain, and CSF samples after administration of (R)-norketamine (10 mg/kg) and (2 R,6 R)-HNK (10 mg/kg), respectively, were higher than those generated after administration of (R)-ketamine (10 mg/kg). Nonetheless, while (R)-ketamine attenuated, neither (R)-norketamine nor (2 R,6 R)-HNK significantly altered immobility times of LPS-treated mice. Treatment with CYP inhibitors prior to administration of (R)-ketamine increased the plasma levels of (R)-ketamine, while generation of (2 R,6 R)-HNK was almost completely blocked. (R)-Ketamine exerted the antidepressant effects at a lower dose in the presence of CYP inhibitors than in their absence, which is consistent with exposure levels of (R)-ketamine but not (2 R,6 R)-HNK. These results indicate that metabolism to (2 R,6 R)-HNK is not necessary for the antidepressant effects of (R)-ketamine and that unmetabolized (R)-ketamine itself may be responsible for its antidepressant actions.},
bibtype = {article},
author = {Yamaguchi, Jun-ichi and Toki, Hidetoh and Qu, Youge and Yang, Chun and Koike, Hiroyuki and Hashimoto, Kenji and Mizuno-yasuhira, Akiko and Chaki, Shigeyuki},
journal = {Neuropsychopharmacology},
number = {April}
}
Downloads: 0
{"_id":"bouRvj924fTaLxsWW","bibbaseid":"yamaguchi-toki-qu-yang-koike-hashimoto-mizunoyasuhira-chaki-2r6rhydroxynorketamineisnotessentialfortheantidepressantactionsofrketamineinmice-2018","downloads":0,"creationDate":"2018-07-20T08:07:38.828Z","title":"(2R,6R)-Hydroxynorketamine is not essential for the antidepressant actions of (R)-ketamine in mice","author_short":["Yamaguchi, J.","Toki, H.","Qu, Y.","Yang, C.","Koike, H.","Hashimoto, K.","Mizuno-yasuhira, A.","Chaki, S."],"year":2018,"bibtype":"article","biburl":null,"bibdata":{"title":"(2R,6R)-Hydroxynorketamine is not essential for the antidepressant actions of (R)-ketamine in mice","type":"article","year":"2018","identifiers":"[object Object]","pages":"0-1","websites":"http://dx.doi.org/10.1038/s41386-018-0084-y","month":"5","publisher":"Nature Publishing Group","day":"3","id":"e5871c3f-12bf-37ff-9ebe-d201071ece8b","created":"2018-05-12T15:03:35.733Z","accessed":"2018-05-12","file_attached":"true","profile_id":"48f1fda5-0084-39cd-8cc7-68fcbd29ae85","group_id":"d9389c6c-8ab5-3b8b-86ed-33db09ca0198","last_modified":"2018-05-31T16:53:46.883Z","tags":"CA","read":false,"starred":false,"authored":false,"confirmed":"true","hidden":false,"citation_key":"Yamaguchi2018","notes":"FL","private_publication":false,"abstract":"(R,S)-Ketamine has rapid and sustained antidepressant effects in depressed patients. Although the metabolism of (R,S)-ketamine to (2 R,6 R)-hydroxynorketamine (HNK), a metabolite of (R)-ketamine, has been reported to be essential for its antidepressant effects, recent evidence suggests otherwise. The present study investigated the role of the metabolism of (R)-ketamine to (2 R,6 R)-HNK in the antidepressant actions of (R)-ketamine. Antidepressant effects were evaluated using the forced swimming test in the lipopolysaccharide (LPS)-induced inflammation model of mice and the tail suspension test in naive mice. To prevent the metabolism of (R)-ketamine to (2 R,6 R)-HNK, mice were pretreated with cytochrome P450 (CYP) inhibitors. The concentrations of (R)-ketamine, (R)-norketamine, and (2 R,6 R)-HNK in plasma, brain, and cerebrospinal fluid (CSF) samples were determined using enantioselective liquid chromatography-tandem mass spectrometry. The concentrations of (R)-norketamine and (2 R,6 R)-HNK in plasma, brain, and CSF samples after administration of (R)-norketamine (10 mg/kg) and (2 R,6 R)-HNK (10 mg/kg), respectively, were higher than those generated after administration of (R)-ketamine (10 mg/kg). Nonetheless, while (R)-ketamine attenuated, neither (R)-norketamine nor (2 R,6 R)-HNK significantly altered immobility times of LPS-treated mice. Treatment with CYP inhibitors prior to administration of (R)-ketamine increased the plasma levels of (R)-ketamine, while generation of (2 R,6 R)-HNK was almost completely blocked. (R)-Ketamine exerted the antidepressant effects at a lower dose in the presence of CYP inhibitors than in their absence, which is consistent with exposure levels of (R)-ketamine but not (2 R,6 R)-HNK. These results indicate that metabolism to (2 R,6 R)-HNK is not necessary for the antidepressant effects of (R)-ketamine and that unmetabolized (R)-ketamine itself may be responsible for its antidepressant actions.","bibtype":"article","author":"Yamaguchi, Jun-ichi and Toki, Hidetoh and Qu, Youge and Yang, Chun and Koike, Hiroyuki and Hashimoto, Kenji and Mizuno-yasuhira, Akiko and Chaki, Shigeyuki","journal":"Neuropsychopharmacology","number":"April","bibtex":"@article{\n title = {(2R,6R)-Hydroxynorketamine is not essential for the antidepressant actions of (R)-ketamine in mice},\n type = {article},\n year = {2018},\n identifiers = {[object Object]},\n pages = {0-1},\n websites = {http://dx.doi.org/10.1038/s41386-018-0084-y},\n month = {5},\n publisher = {Nature Publishing Group},\n day = {3},\n id = {e5871c3f-12bf-37ff-9ebe-d201071ece8b},\n created = {2018-05-12T15:03:35.733Z},\n accessed = {2018-05-12},\n file_attached = {true},\n profile_id = {48f1fda5-0084-39cd-8cc7-68fcbd29ae85},\n group_id = {d9389c6c-8ab5-3b8b-86ed-33db09ca0198},\n last_modified = {2018-05-31T16:53:46.883Z},\n tags = {CA},\n read = {false},\n starred = {false},\n authored = {false},\n confirmed = {true},\n hidden = {false},\n citation_key = {Yamaguchi2018},\n notes = {FL},\n private_publication = {false},\n abstract = {(R,S)-Ketamine has rapid and sustained antidepressant effects in depressed patients. Although the metabolism of (R,S)-ketamine to (2 R,6 R)-hydroxynorketamine (HNK), a metabolite of (R)-ketamine, has been reported to be essential for its antidepressant effects, recent evidence suggests otherwise. The present study investigated the role of the metabolism of (R)-ketamine to (2 R,6 R)-HNK in the antidepressant actions of (R)-ketamine. Antidepressant effects were evaluated using the forced swimming test in the lipopolysaccharide (LPS)-induced inflammation model of mice and the tail suspension test in naive mice. To prevent the metabolism of (R)-ketamine to (2 R,6 R)-HNK, mice were pretreated with cytochrome P450 (CYP) inhibitors. The concentrations of (R)-ketamine, (R)-norketamine, and (2 R,6 R)-HNK in plasma, brain, and cerebrospinal fluid (CSF) samples were determined using enantioselective liquid chromatography-tandem mass spectrometry. The concentrations of (R)-norketamine and (2 R,6 R)-HNK in plasma, brain, and CSF samples after administration of (R)-norketamine (10 mg/kg) and (2 R,6 R)-HNK (10 mg/kg), respectively, were higher than those generated after administration of (R)-ketamine (10 mg/kg). Nonetheless, while (R)-ketamine attenuated, neither (R)-norketamine nor (2 R,6 R)-HNK significantly altered immobility times of LPS-treated mice. Treatment with CYP inhibitors prior to administration of (R)-ketamine increased the plasma levels of (R)-ketamine, while generation of (2 R,6 R)-HNK was almost completely blocked. (R)-Ketamine exerted the antidepressant effects at a lower dose in the presence of CYP inhibitors than in their absence, which is consistent with exposure levels of (R)-ketamine but not (2 R,6 R)-HNK. These results indicate that metabolism to (2 R,6 R)-HNK is not necessary for the antidepressant effects of (R)-ketamine and that unmetabolized (R)-ketamine itself may be responsible for its antidepressant actions.},\n bibtype = {article},\n author = {Yamaguchi, Jun-ichi and Toki, Hidetoh and Qu, Youge and Yang, Chun and Koike, Hiroyuki and Hashimoto, Kenji and Mizuno-yasuhira, Akiko and Chaki, Shigeyuki},\n journal = {Neuropsychopharmacology},\n number = {April}\n}","author_short":["Yamaguchi, J.","Toki, H.","Qu, Y.","Yang, C.","Koike, H.","Hashimoto, K.","Mizuno-yasuhira, A.","Chaki, S."],"urls":{"Paper":"https://bibbase.org/service/mendeley/38c6dbcb-2394-3f18-9217-58d777c08c69/file/1cf63733-6a25-56c9-14ab-375c727dbfe3/full_text.pdf.pdf","Website":"http://dx.doi.org/10.1038/s41386-018-0084-y"},"bibbaseid":"yamaguchi-toki-qu-yang-koike-hashimoto-mizunoyasuhira-chaki-2r6rhydroxynorketamineisnotessentialfortheantidepressantactionsofrketamineinmice-2018","role":"author","downloads":0},"search_terms":["hydroxynorketamine","essential","antidepressant","actions","ketamine","mice","yamaguchi","toki","qu","yang","koike","hashimoto","mizuno-yasuhira","chaki"],"keywords":[],"authorIDs":[]}